ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      60,116.92
      1.49%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. AbbVie Inc (ABBV)

      7. AbbVie Inc (ABBV) News

      ABBV

      AbbVie (ABBV)

      AbbVie Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:ABBV
      DateTimeSourceHeadlineSymbolCompany
      02/22/20216:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      02/22/20216:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      02/22/20216:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      02/22/20216:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      02/22/20216:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      02/22/20216:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      02/22/20216:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      02/22/20216:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      02/22/20216:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      02/22/20218:45AMPR Newswire (US)Second Phase 3 Induction Study Confirms Upadacitinib (RINVOQ™) Improved Clinical, Endoscopic and Histologic Outcomes in Ulc...NYSE:ABBVAbbVie Inc
      02/21/20211:11PMTipRanksBillionaire Ray Dalio Places Bet on 3 “Strong Buy” StocksNYSE:ABBVAbbVie Inc
      02/19/20212:07PMEdgar (US Regulatory)Annual Report (10-k)NYSE:ABBVAbbVie Inc
      02/19/202110:02AMDow Jones NewsAbbVie, Evolus, Medytox Resolve Intellectual-Property LitigationNYSE:ABBVAbbVie Inc
      02/19/20219:15AMPR Newswire (US)AbbVie, Evolus, and Medytox Announce Resolution of Intellectual Property LitigationNYSE:ABBVAbbVie Inc
      02/19/20218:00AMPR Newswire (US)AbbVie to Present at the Cowen 41st Annual Health Care ConferenceNYSE:ABBVAbbVie Inc
      02/18/202110:58AMPR Newswire (US)AbbVie Declares Quarterly DividendNYSE:ABBVAbbVie Inc
      02/16/20217:18PMDow Jones NewsBuffett's Berkshire Hathaway Bets Billions on Verizon and Chevron -- UpdateNYSE:ABBVAbbVie Inc
      02/16/20213:47PMEdgar (US Regulatory)Schedule 13gNYSE:ABBVAbbVie Inc
      02/12/20218:00AMPR Newswire (US)AbbVie to Present at the 10th Annual SVB Leerink Global Healthcare ConferenceNYSE:ABBVAbbVie Inc
      02/10/202110:31AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:ABBVAbbVie Inc
      02/10/20219:16AMDow Jones NewsAllergan's Botox Gets FDA OK for Bladder-Muscle Overactivity in ChildrenNYSE:ABBVAbbVie Inc
      02/10/20218:57AMDow Jones NewsAbbVie, Caribou Biosciences to Collaborate on CAR-T Cell ProductsNYSE:ABBVAbbVie Inc
      02/10/20218:15AMPR Newswire (US)AbbVie and Caribou Biosciences Announce Collaboration and License Agreement for CAR-T Cell ProductsNYSE:ABBVAbbVie Inc
      02/10/20218:00AMPR Newswire (US)BOTOX® (onabotulinumtoxinA) Receives FDA Approval for Pediatric Detrusor Overactivity Associated with a Neurologic ConditionNYSE:ABBVAbbVie Inc
      02/03/202110:15AMTipRanksAbbVie’s 4Q Profit Tops Analysts’ Estimates; Shares GainNYSE:ABBVAbbVie Inc
      02/03/20218:29AMDow Jones NewsAbbVie Sees Stronger 2021 ProfitNYSE:ABBVAbbVie Inc
      02/03/20218:27AMDow Jones NewsAbbVie Logs Higher Sales, Strong Adjusted Profit in 4QNYSE:ABBVAbbVie Inc
      02/03/20217:38AMPR Newswire (US)AbbVie Reports Full-Year and Fourth-Quarter 2020 Financial ResultsNYSE:ABBVAbbVie Inc
      01/29/20216:07AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:ABBVAbbVie Inc
      01/26/20218:45AMPR Newswire (US)CoolSculpting® by Allergan Aesthetics Expands Body Contouring Portfolio With CoolSculpting® EliteNYSE:ABBVAbbVie Inc
       Showing the most relevant articles for your search:NYSE:ABBV